FDA Inspection
Go2PharmaGo2Pharma – FDA Inspection, Nov 1, 2019
Record Details
This FDA Inspection record concerns Go2Pharma, with an inspection on November 1, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Go2Pharma
- Inspection Date
- November 1, 2019
- Product Type
- Drugs
View Company Profile
ID · 448ff865-0f07-4914-ba24-539cfe1ec88d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1110494
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.25(c)Inadequate number of personnel
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.